Rhythm Pharmaceuticals (RYTM) Asset Utilization Ratio (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Asset Utilization Ratio of 0.47 for Q1 2026, up 33.98% year-over-year from 0.35 in Q1 2025, and up 22.45% quarter-over-quarter from 0.38 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Asset Utilization Ratio for 6 consecutive years, with 0.47 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 33.98% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (up 33.98% YoY), while the FY2025 annual figure was 0.43, up 21.18% from the prior year.
- Asset Utilization Ratio improved to 0.47 in Q1 2026 per RYTM's latest filing, from 0.38 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.47 in Q1 2026 and bottomed at 0.02 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.23 across 5 years, with a median of 0.3 in 2024.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 1179.79% — and 2025, when it advanced 11.67%.
- Rhythm Pharmaceuticals' Asset Utilization Ratio stood at 0.02 in 2022, then jumped by 1179.79% to 0.23 in 2023, then jumped by 52.74% to 0.34 in 2024, then increased by 11.67% to 0.38 in 2025, then increased by 22.45% to 0.47 in 2026.
- Business Quant data shows RYTM's Asset Utilization Ratio at 0.47 in Q1 2026, 0.38 in Q4 2025, and 0.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.55 |
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.40 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.35 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.30 |
| Jun 30, 2024 | 0.32 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.23 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.01 |